Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells. The study is being published this week in PNAS.
Cloned receptor paves way for new breast and prostate cancer treatment
- EurekAlert
- 13. 9 2012 (06:00)